Reference | Setting | Total patients consented/total tested | Timing of tests post-stroke | Test done | Subtyping | Primary outcome | Results |
---|---|---|---|---|---|---|---|
Nys 20078 9 | Hospital The Netherlands | 190/168* | 3 weeks | NP† | Imaging | MCI‡ | 29/64 (45%)§ Lacunar 47/63 (75%)§ Non-lacunar |
Sachdev et al10 | Hospital Australia | 210/170* | 3–6 months | NP | Risk factor | Dementia or MCI | 24/46 (52%) Lacunar 74/120 (62%) Non-lacunar |
De Koning et al11 | Hospital The Netherlands | 130/121* | 3–9 months | NP | Imaging | Dementia | 4/20 (20%) Lacunar¶ 17/38 (45%) Non-lacunar¶ |
Censori et al12 | Hospital Italy | 121/110** | 3–4 Months | NP and MMSE†† | Clinical | Dementia | 2/21 (10%) Lacunar 13/83 (16%)Non-lacunar |
Tatemichi et al13 | Hospital USA | 927/726 | 2 years | Clinical impression | Risk factor | Dementia | 25/227 (11%) Lacunar 91/499 (18%) Non-lacunar |
Bejot et al14 | Community France | 3948/3201* | 1 month | NP | Risk factor | Dementia | 333/887 (38%) Lacunar 289/1960 (15%) Non-lacunar |
Lin et al15 | Hospital Taiwan | 353/283 | 3 months | NP | Risk factor | Dementia | 13/136 (10%) Lacunar 13/147 (9%) Non-lacunar |
Patel et al16 17 | Community UK | 1454/654* | 3 months | MMSE | Clinical | MMSE<24 | 72/218 (33%) Lacunar 124/297 (42%) Non-lacunar |
Cordoliani-Mackowiak et al18 | Hospital France | 132/88‡‡ | Up to 3 years | NP | Risk factor | Dementia | 8/31 (26%) Lacunar 24/101 (24%) Non-lacunar |
Rasquin et al19–22 | Hospital The Netherlands | 176/144 | 1 years | NP | Imaging | MCI or Dementia | 40/57 (70%) Lacunar 59/87 (68%) Non-lacunar§§ |
Pohjasvaara et al23 | Hospital Finland | 451/337 | 3 months | NP | Risk factor | Dementia | 5/21 (24%) Lacunar 102/316 (32%) Non-lacunar |
Tang et al24 | Hospital China | 484/280* | 3 months | MMSE | Imaging | Dementia | 33/166 (20%) Lacunar 18/90 (20%) Non-lacunar |
Madureira et al25 | Hospital Portugal | 180/165 | 3 months | NP | Imaging | Dementia | 6/139 (4.3%) Lacunar¶¶ 5/41 (12%) Non-lacunar¶¶ |
Klimkowicz-Mrowiec et al26 | Hospital Poland | 173/145‡‡* | 3 months | NP and MMSE | Clnical | Dementia | 2/24 (8%) Lacunar 35/149 (23%) Non-lacunar |
Dong et al27 | Hospital Singapore | 300/239* | 3–6 months | NP, MMSE, and MoCA§§ | Risk factor | Moderate MCI | 21/106 (20%) Lacunar 31/97 (33%) Non-lacunar |
Tatemichi et al28 | Hospital USA | Not stated/227 | 3 months | NP | Clinical | MCI | 21/59 (36%) Lacunar 59/168 (35%) Non-lacunar |
Tay et al29 | Hospital Singapore | 216/169 | 9 days | MMSE | Clinical | NA | Mean MMSE Non-lacunar (anterior circulation)18.2, Lacunar 22.9 |
Mok et al30 | Hospital China | 86/75 | 3 months*** | MMSE and clinical dementia rating scale | Imaging | Dementia | 10/75 (13%) Mean MMSE: 24.8 lacunar, 27.7 healthy controls |
Samuelsson et al31 | Hospital Sweden | 100/81 | 2 years | MMSE and NP if impaired. | Clinical | Dementia | 8/81 (10%) |
Anderson et al32 | Community Australia | Not stated/30 | 1 year | NP | Clinical | MCI | 2/30 (7%) |
Loeb et al33 | Hospital Italy | Not stated/108 | Up to 4 years | MMSE | Clinical | Dementia | 25/108 (23%) |
Fure et al34 | Hospital Norway | 71/64‡‡ | 2–7 days | NP | Risk factor | MCI | 41/71 (58%) |
Barker-Collo et al35 | Community New Zealand | 357/336 | 5 years | NP | Clinical | Cognition test results. | No difference in mean test scores |
Appelros et al36 | Community Sweden | 253/232* | 1 year | MMSE | Risk factor | Mean MMSE scores | Mean MMSE Non-lacunar 25.6, Lacunar 26.6 |
*Includes subjects with haemorrhagic stroke/transient ischaemic attack.
†Full neuropsychological (NP) testing.
‡Mild cognitive impairment.
§14 haemorrhagic strokes included in these figures.
¶Subtype reported only in patients who had a visible lesion on CT.
**Six subjects with specific cognitive impairment excluded.
††Mini-Mental State Examination.
‡‡Data reported on subjects who could not have full tests.
§§Calculated from reported OR.
¶¶Calculated from χ2 statistic.
***The 61 non-demented patients were followed up 2–3 years later; no information on outcome of those who did have dementia at 3 months.37
§§MoCA, Montreal Cognitive Assessment.